-
1 Comment
Nipro Corporation is currently in a long term uptrend where the price is trading 5.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Nipro Corporation's total revenue rose by 4.2% to $119B since the same quarter in the previous year.
Its net income has dropped by 1.4% to $5B since the same quarter in the previous year.
Based on the above factors, Nipro Corporation gets an overall score of 3/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3673600007 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Beta | 0.02 |
|---|---|
| Market Cap | 215B |
| PE Ratio | 47.96 |
| Target Price | 1412 |
| Dividend Yield | 3.0% |
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers. The company's Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies. The business also provides injectable and oral drugs products. Its PharmaPackaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, as well glass for ampoules. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Settsu, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8086.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
